How CGM technology works
A continuous glucose monitor is, at its core, a miniaturized electrochemical biosensor combined with wireless communication technology. It works by detecting a chemical reaction between glucose molecules and an enzyme on the sensor tip, converting that reaction into an electrical signal, and transmitting that signal to a display device.
The entire process — from glucose molecule contacting the sensor to a reading appearing on your phone — happens in seconds, and repeats every one to five minutes, 24 hours a day, for the lifetime of the sensor.
Layer 1 — Biochemistry
Glucose in interstitial fluid reacts with glucose oxidase enzyme on the sensor filament. This enzymatic reaction produces hydrogen peroxide proportional to glucose concentration — the chemical signal that begins the measurement chain.
Layer 2 — Electrochemistry
The hydrogen peroxide is oxidized at a platinum electrode, generating a tiny electrical current. This amperometric current — measured in nanoamperes — is directly proportional to the glucose concentration in the surrounding fluid.
Layer 3 — Signal processing
Raw electrical signals are noisy and require calibration. Algorithms in the transmitter correct for sensor drift, temperature variation, tissue response, and other confounding factors to convert the raw current into an accurate glucose value in mg/dL or mmol/L.
Layer 4 — Wireless transmission
The processed glucose value, along with trend and signal quality data, is transmitted via Bluetooth Low Energy to a receiver, smartphone, or smartwatch. Modern CGM systems transmit every one to five minutes and maintain connectivity at ranges up to 6–9 meters.
The electrochemistry of glucose sensing
The core of every CGM sensor is an amperometric enzyme electrode — a technology that has been refined over decades from laboratory instruments into something small enough to wear under the skin for two weeks.
The glucose oxidase reaction
The enzyme glucose oxidase (GOx) catalyzes a specific chemical reaction: it converts glucose and oxygen into gluconic acid and hydrogen peroxide. This reaction is highly specific to glucose — it will not respond to other sugars or molecules in interstitial fluid, which is essential for accuracy.
The reaction can be written as: Glucose + O₂ → Gluconic acid + H₂O₂
The hydrogen peroxide produced is then oxidized at a platinum working electrode, releasing two electrons per molecule. This generates a measurable electrical current. Since the current is proportional to the hydrogen peroxide concentration — which is proportional to the glucose concentration — measuring the current gives a glucose reading.
The three-electrode system
CGM sensors use a three-electrode electrochemical cell: a working electrode (where glucose oxidation occurs), a reference electrode (which provides a stable voltage reference), and a counter electrode (which completes the electrical circuit). This three-electrode design is more stable and accurate than a simpler two-electrode system, particularly over multi-day sensor wear periods.
Membrane layers and selectivity
The sensor filament is coated with multiple membrane layers, each serving a specific function. An outer biocompatible membrane controls glucose flux into the sensor, preventing enzyme saturation at high glucose levels. An interference-rejecting membrane blocks electroactive molecules (such as acetaminophen and uric acid) that could falsely elevate readings. The enzyme layer contains immobilized glucose oxidase. An inner inner membrane controls access to the electrode surface.
The design and composition of these membranes is where much of the differentiation between CGM manufacturers lies — and where the most significant engineering has occurred over successive product generations.
The glucose oxidase reaction requires oxygen as a co-substrate. In tissue, oxygen concentration is lower and more variable than in blood, which can affect sensor accuracy. Modern CGM sensors use membrane engineering and algorithms to compensate for oxygen variability — but it remains a fundamental constraint of enzyme-based glucose sensing.
The three components of a CGM system
Generations of CGM technology
CGM technology has advanced through several distinct generations, each bringing meaningful improvements in accuracy, wear time, ease of use, and accessibility.
| Generation | Calibration | Wear time | MARD | Key advance |
|---|---|---|---|---|
| 1st gen (pre-2015) | 2–4x daily | 3–7 days | 14–18% | Proof of concept — continuous monitoring possible |
| 2nd gen (2015–2018) | 2x daily | 7–10 days | 10–13% | Improved accuracy, longer wear, smartphone integration |
| 3rd gen (2018–2022) | Factory calibrated | 10–14 days | 8–10% | No finger-stick calibration required, Dexcom G6, Libre 2 |
| Current gen (2022–) | Factory calibrated | 14–15 days | 7–9% | OTC availability, smaller form factor, direct-to-watch, Dexcom G7/Stelo, Libre 3 |
| Next gen (emerging) | Factory calibrated | 15–30+ days | <7% target | Implantable sensors, non-enzymatic sensing, multi-analyte measurement |
The shift to factory calibration — removing the requirement for twice-daily finger-stick calibrations — was the most transformative usability advance in CGM history. It eliminated a major barrier to adoption and enabled CGM use in situations (such as overnight wear) where stopping to calibrate was impractical.
Understanding CGM accuracy and MARD
CGM accuracy is measured using Mean Absolute Relative Difference (MARD) — the average percentage difference between CGM readings and simultaneous laboratory blood glucose measurements. A MARD of 9% means the CGM reading is, on average, within 9% of the true blood glucose value.
A MARD of 8% at a blood glucose of 100 mg/dL means the CGM reading may be anywhere from 92–108 mg/dL. At 200 mg/dL, the range widens to 184–216 mg/dL. For most clinical decisions this is acceptably accurate, but it is why finger-stick verification remains important for critical treatment decisions.
Factors that improve accuracy
Factory calibration algorithms trained on large datasets · Proper sensor insertion site and technique · Avoiding compression of the sensor (sleeping on it) · Stable glucose levels (less lag effect) · Adequate hydration · Sensor in the middle of its wear period
Factors that reduce accuracy
Rapidly changing glucose (meals, exercise, hypoglycemia) · First 24 hours of sensor wear · Sensor compression during sleep · High-dose acetaminophen or other interfering medications · Extreme temperatures · End of sensor wear period · Improper insertion site or technique
The interstitial lag — why CGM lags blood glucose
CGM sensors measure glucose in interstitial fluid — the fluid that surrounds cells in subcutaneous tissue — not glucose in blood directly. Glucose moves from blood capillaries into interstitial fluid by diffusion, a process that takes time.
This physiological delay means that during periods of rapidly changing blood glucose, the CGM reading lags behind the true blood glucose by approximately 5–15 minutes. When blood glucose is rising quickly after a meal, CGM will underestimate the true peak. When glucose is falling rapidly during hypoglycemia, CGM may underestimate the severity.
How trend arrows compensate for lag
Trend arrows on CGM displays indicate the direction and rate of glucose change, helping users anticipate where glucose is heading rather than just where it appears to be. An arrow showing rapidly falling glucose is a warning to act even if the displayed number is not yet in the low range. Understanding trend arrows is essential for safe CGM use, particularly for insulin-using patients.
| Trend arrow | Meaning | Rate of change |
|---|---|---|
| ↑↑ Double up | Rising rapidly | >3 mg/dL per minute |
| ↑ Single up | Rising | 2–3 mg/dL per minute |
| ↗ Angled up | Rising slowly | 1–2 mg/dL per minute |
| → Flat | Stable | <1 mg/dL per minute |
| ↘ Angled down | Falling slowly | 1–2 mg/dL per minute |
| ↓ Single down | Falling | 2–3 mg/dL per minute |
| ↓↓ Double down | Falling rapidly | >3 mg/dL per minute |
How to respond to trend arrows — particularly for insulin dosing decisions — should be determined in consultation with your healthcare provider. Many providers use published trend arrow adjustment guidelines, but these must be individualized. Never adjust insulin doses based on CGM trend arrows without guidance from your diabetes care team.
The future of CGM technology
CGM technology is advancing rapidly across several dimensions — longer wear, higher accuracy, non-invasive sensing, and measurement of additional analytes beyond glucose.